These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 2691130
1. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study. Bounhoure JP, Bottineau G, Lechat P, Garnham J, Lapeyre G. Clin Exp Hypertens A; 1989; 11 Suppl 2():575-86. PubMed ID: 2691130 [Abstract] [Full Text] [Related]
2. [Perindopril and chronic heart failure]. Bounhoure JP. Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331 [Abstract] [Full Text] [Related]
3. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo]. Bounhoure JP, Bottineau G, Lechat P, Garnham J, Lapeyre G. Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716 [Abstract] [Full Text] [Related]
4. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril. Forette F, McClaran J, Delesalle MC, Hervy MP, Bouchacourt P, Henry-Amar M, Santoni JP. Clin Exp Hypertens A; 1989 May; 11 Suppl 2():587-603. PubMed ID: 2691131 [Abstract] [Full Text] [Related]
5. Effect of perindopril in pacing-induced canine models of acute and chronic heart failure. Ogilvie RI, Zborowska-Sluis D. Can J Cardiol; 1995 Nov; 11(10):934-40. PubMed ID: 7489534 [Abstract] [Full Text] [Related]
6. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience. Navookarasu NT, Rahman AR, Abdullah I. Int J Clin Pract; 1999 Nov; 53(1):25-30. PubMed ID: 10344062 [Abstract] [Full Text] [Related]
7. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L. Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [Abstract] [Full Text] [Related]
8. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators. Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606 [Abstract] [Full Text] [Related]
9. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study]. Assmann I, Kassel P, Duck HG, Fiehring H, Morgan P, Schmidt PK, Höfs T, Nehmiz G. Z Kardiol; 1991 Nov 27; 80(11):687-94. PubMed ID: 1792811 [Abstract] [Full Text] [Related]
10. Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure. Lechat P, Garnham SP, Desche P, Bounhoure JP. Am Heart J; 1993 Sep 27; 126(3 Pt 2):798-806. PubMed ID: 8166887 [Abstract] [Full Text] [Related]
11. The acute effect of perindopril upon effort capacity in congestive heart failure. Zdrenghea D, Angheloiu O, Icusca G, Timiş D. Rom J Intern Med; 1994 Sep 27; 32(4):265-9. PubMed ID: 7613498 [Abstract] [Full Text] [Related]
12. [A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure]. Jerie P, Kremer HJ, Uhlír O, Widimský J. Vnitr Lek; 1997 Jun 27; 43(6):351-8. PubMed ID: 9601863 [Abstract] [Full Text] [Related]
13. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J, PEP-CHF Investigators. Eur Heart J; 2006 Oct 27; 27(19):2338-45. PubMed ID: 16963472 [Abstract] [Full Text] [Related]
14. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE. Arterioscler Thromb Vasc Biol; 2004 Jun 27; 24(6):1043-8. PubMed ID: 15105283 [Abstract] [Full Text] [Related]
15. [The long-term administration of perindopril improves the hemodynamic status of rats with heart failure]. Medvedev OS, Zakharova NV. Eksp Klin Farmakol; 1994 Jun 27; 57(6):26-9. PubMed ID: 7756952 [Abstract] [Full Text] [Related]
16. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril]. Forette F, McClaran JM, Delesalle MC, Hervy MP, Bouchacourt P, Henry-Amar M, Santoni JP. Arch Mal Coeur Vaiss; 1989 May 27; 82 Spec No 1():79-85. PubMed ID: 2505717 [Abstract] [Full Text] [Related]
17. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure. Schalcher C, Cotter G, Reisin L, Bertel O, Kobrin I, Guyene TT, Kiowski W. Am Heart J; 2001 Aug 27; 142(2):340-9. PubMed ID: 11479476 [Abstract] [Full Text] [Related]
18. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy. Bönner G, Lederle RM, Scholze J, Stumpe KO. Arzneimittelforschung; 1993 Aug 27; 43(8):852-5. PubMed ID: 8216441 [Abstract] [Full Text] [Related]
19. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure]. Tereshchenko SN, Drozdov VN, Demidova IV, Levchuk NN, Moiseev VS. Ter Arkh; 1997 Aug 27; 69(7):53-6. PubMed ID: 9424761 [Abstract] [Full Text] [Related]
20. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure. Sami MH. Can J Cardiol; 1994 Nov 27; 10 Suppl D():13D-16D. PubMed ID: 7954033 [Abstract] [Full Text] [Related] Page: [Next] [New Search]